News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Lytix Biopharma announces expansion of the ATLAS-IT-05 study to Europe
Monday, November 14, 2022Lytix Biopharma a Norwegian immunooncology company today announces site activation for the ATLASIT study in three European countries ATLASIT is a Phase II combination study evaluating LTX and pembrolizumab in patients with advanced melanoma The study...
BeiGene Announces Brazil Approvals for BRUKINSA® As a Treatment for Rare Blood Cancers
Friday, November 11, 2022BeiGene a global biotechnology today announced BRUKINSA zanubrutinib has been approved in Brazil for the treatment of adult patients with Waldenstrms macroglobulinemia WM and adult patients with relapsedrefractory RR marginal zone lymphoma MZL who ha...
Scipher Medicine Announces Publication of Positive Results From AIMS Clinical Study
Friday, November 11, 2022Scipher Medicine announced data validating the clinical utility of the companys PrismRA test for guiding treatment selection for rheumatoid arthritis RA patients The latest publication in the Expert Review of Molecular Diagnostics showed that patient...
NanoString and Abcam Expand Collaboration to Advance Spatial Multiomics Research
Thursday, November 10, 2022NanoString Technologies Inc a leading provider of life science tools for discovery and translational research and Abcam a global life science company working together
TILT Biotherapeutics Announces Boston Office Opening as it Expands its Clinical Trials in the US
Thursday, November 10, 2022TILT Biotherapeutics a clinicalstage biotechnology company developing cancer immunotherapies announces that the company has opened an office in Boston to support its increasing US clinical development partnering and fundraising activities The current...
Salipro Biotech enters into collaboration and license agreement with Sanofi to advance discovery programs
Wednesday, November 09, 2022Swedish biotech company Salipro Biotech AB today announced that it has entered into a research collaboration and license agreement with Sanofi on the discovery of therapeutic biologics against a challenging drug target The collaboration brings togeth...
Portage Biotech Announces Clinical Trial Collaboration Agreement with Merck
Wednesday, November 09, 2022Portage Biotech Inc a clinicalstage immunooncology company developing therapies to improve patient lives and increase survival by avoiding and overcoming cancer
Aleta Biotherapeutics Receives Innovation Passport Designation for Biologic CAR T-Cell Therapy Engager ALETA-001
Tuesday, November 08, 2022Aleta Biotherapeutics Aleta a privately held immunooncology company with novel biologic CAR T engagers that work in synergy with cell therapies to improve outcomes for patients
Nucleai Launches New Multiplex Imaging Spatial Analysis Solution to Increase Reliability and Speed of Immunofluorescence Analysis for Drug Discovery and Development
Tuesday, November 08, 2022Nucleai a leader in AIpowered spatial biology today announced the expansion of its spatial biology platform to include a new generation of multiplex immunofluorescence mIF analysis that uses deep learning to establish new levels of accuracy speed and...
Shuttle Pharmaceuticals Engages Theradex Oncology in Preparation for Clinical Study
Friday, November 04, 2022Shuttle Pharmaceuticals Holdings Inc a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy RT while reducing its side effects today announced it has enga...
